Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Basal-like breast carcinoma: from expression profiling to routine practice.

Rakha E, Reis-Filho JS.

Arch Pathol Lab Med. 2009 Jun;133(6):860-8. doi: 10.1043/1543-2165-133.6.860. Review.

PMID:
19492878
[PubMed - indexed for MEDLINE]
2.

The phenotypic spectrum of basal-like breast cancers: a critical appraisal.

Fadare O, Tavassoli FA.

Adv Anat Pathol. 2007 Sep;14(5):358-73. Review.

PMID:
17717437
[PubMed - indexed for MEDLINE]
3.

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.

Tan DS, Marchió C, Jones RL, Savage K, Smith IE, Dowsett M, Reis-Filho JS.

Breast Cancer Res Treat. 2008 Sep;111(1):27-44. Epub 2007 Oct 6.

PMID:
17922188
[PubMed - indexed for MEDLINE]
4.

The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.

Zhang H, Rakha EA, Ball GR, Spiteri I, Aleskandarany M, Paish EC, Powe DG, Macmillan RD, Caldas C, Ellis IO, Green AR.

Breast Cancer Res Treat. 2010 May;121(1):41-51. doi: 10.1007/s10549-009-0450-x. Epub 2009 Jul 10.

PMID:
19590950
[PubMed - indexed for MEDLINE]
5.

Basal-like immunophenotype markers and prognosis in early breast cancer.

Cassol L, Silveira Graudenz M, Zelmanowicz A, Cancela A, Werutsky G, Rovere RK, Garicochea B.

Tumori. 2010 Nov-Dec;96(6):966-70.

PMID:
21388060
[PubMed - indexed for MEDLINE]
6.

Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features.

Ishihara A, Tsuda H, Kitagawa K, Yoneda M, Shiraishi T.

Breast Cancer. 2009;16(3):179-85. doi: 10.1007/s12282-009-0108-x. Epub 2009 May 23.

PMID:
19466513
[PubMed - indexed for MEDLINE]
7.

Refinement of breast cancer classification by molecular characterization of histological special types.

Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, de Jong D, Van de Vijver MJ, Van't Veer LJ, Peterse JL.

J Pathol. 2008 Oct;216(2):141-50. doi: 10.1002/path.2407.

PMID:
18720457
[PubMed - indexed for MEDLINE]
8.

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S.

J Clin Pathol. 2008 Mar;61(3):327-32. Epub 2007 Nov 23.

PMID:
18037662
[PubMed - indexed for MEDLINE]
9.

Expression profiling technology: its contribution to our understanding of breast cancer.

Rakha EA, El-Sayed ME, Reis-Filho JS, Ellis IO.

Histopathology. 2008 Jan;52(1):67-81. doi: 10.1111/j.1365-2559.2007.02894.x. Review.

PMID:
18171418
[PubMed - indexed for MEDLINE]
10.

Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.

González LO, Corte MD, Junquera S, González-Fernández R, del Casar JM, García C, Andicoechea A, Vázquez J, Pérez-Fernández R, Vizoso FJ.

Hum Pathol. 2009 Sep;40(9):1224-33. doi: 10.1016/j.humpath.2008.12.022. Epub 2009 May 12.

PMID:
19439346
[PubMed - indexed for MEDLINE]
11.

[Breast cancer and molecular markers].

Ishioka C.

Gan To Kagaku Ryoho. 2008 Aug;35(8):1261-8. Review. Japanese.

PMID:
18701834
[PubMed - indexed for MEDLINE]
12.

Basal carcinoma of the breast revisited: an old entity with new interpretations.

Korsching E, Jeffrey SS, Meinerz W, Decker T, Boecker W, Buerger H.

J Clin Pathol. 2008 May;61(5):553-60. doi: 10.1136/jcp.2008.055475. Epub 2008 Mar 6. Review.

PMID:
18326009
[PubMed - indexed for MEDLINE]
13.

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.

Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO.

Int J Cancer. 2005 Sep 1;116(3):340-50.

PMID:
15818618
[PubMed - indexed for MEDLINE]
14.

Gene expression profiling in breast cancer.

Nasser SM.

J Med Liban. 2009 Apr-Jun;57(2):83-8.

PMID:
19623883
[PubMed - indexed for MEDLINE]
15.

The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?

Fadare O, Wang SA, Hileeto D.

Hum Pathol. 2008 Mar;39(3):331-6. doi: 10.1016/j.humpath.2007.07.014.

PMID:
18261623
[PubMed - indexed for MEDLINE]
16.

Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer.

Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, Tan PH.

Mod Pathol. 2010 Jan;23(1):123-33. doi: 10.1038/modpathol.2009.145. Epub 2009 Oct 23.

PMID:
19855377
[PubMed - indexed for MEDLINE]
Free Article
17.

Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.

Kusińska R, Potemski P, Jesionek-Kupnicka D, Kordek R.

Pol J Pathol. 2005;56(3):107-10.

PMID:
16334976
[PubMed - indexed for MEDLINE]
18.

Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.

Huber KE, Carey LA, Wazer DE.

Semin Radiat Oncol. 2009 Oct;19(4):204-10. doi: 10.1016/j.semradonc.2009.05.004. Review.

PMID:
19732684
[PubMed - indexed for MEDLINE]
19.

[Clinicopathologic characteristics of breast cancer with basal-like immunophenotype].

Wu WX, Han WL, Zhang YP, Yu QX, Wen XW, Lu N, Tang ZY, Yuan LN, Zhang Y, Wang Z, Wang W, Yang HJ, Chen CP, Guo WL.

Zhonghua Bing Li Xue Za Zhi. 2008 Nov;37(11):743-8. Chinese.

PMID:
19094708
[PubMed - indexed for MEDLINE]
20.

Biologic profiling of lymph node negative breast cancers by means of microRNA expression.

Janssen EA, Slewa A, Gudlaugsson E, Jonsdottir K, Skaland I, Søiland H, Baak JP.

Mod Pathol. 2010 Dec;23(12):1567-76. doi: 10.1038/modpathol.2010.177. Epub 2010 Sep 3.

PMID:
20818337
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk